Therefore, CDK inhibitors successfully reduced the expressions of pSTAT3 and transcriptional target genes such as cyclin B1 and IL-6, leading to apoptosis of lung squamous cell carcinoma (LUSC) cells and inhibition of tumor growth in patient-derived xenograft (PDX) models [66,67]. This evidence concerns the gene IL6 and neoplasm.